Skip to main content

KILL Dr. Charles Howe of the Mayo Clinic’s Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt’s Subsidiary Adimune™

Aditxt, Inc. requests that their press release NewsItemId: 20250417385764 “Dr. Charles Howe of the Mayo Clinic’s Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt’s Subsidiary Adimune™” be killed.

The release was issued in error by Aditxt, Inc..

A replacement release will not be issued at this time.

Contacts

Aditxt, Inc.

Corporate Communications

Jeff Ramson, PCG Advisory, Inc.

T: 646-863-6893

contactus@aditxt.com

Recent Quotes

View More
Symbol Price Change (%)
AMZN  212.79
+3.02 (1.44%)
AAPL  258.86
+2.94 (1.15%)
AMD  220.18
+2.68 (1.23%)
BAC  50.06
+0.68 (1.38%)
GOOG  297.66
+3.20 (1.09%)
META  573.02
-1.44 (-0.25%)
MSFT  372.88
-0.58 (-0.16%)
NVDA  177.64
+0.25 (0.14%)
ORCL  145.54
-0.84 (-0.57%)
TSLA  352.82
-7.77 (-2.15%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.